James Kahn, MD

Email James
(415) 476-4082 x408

3333 California Street
San Francisco, CA 94118

Visit CTSI Profile

  • Professor, School of Medicine
  • Mentoring Program Director

Displaying 1 - 171 of 171

  1. Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay GR, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California. Am J Respir Crit Care Med. 2020 02 01; 201(3):356-365. View on Pubmed
  2. Heller DJ, Balzer LB, Kazi D, Charlebois ED, Kwarisiima D, Mwangwa F, Jain V, Kotwani P, Chamie G, Cohen CR, Clark TD, Ayieko J, Byonanabye DM, Petersen M, Kamya MR, Havlir D, Kahn JG. Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation. PLoS One. 2020; 15(1):e0222801. View on Pubmed
  3. Cai C, Runte J, Ostrer I, Berry K, Ponce N, Rodriguez M, Bertozzi S, White JS, Kahn JG. Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses. PLoS Med. 2020 01; 17(1):e1003013. View on Pubmed
  4. Huchko MJ, Olwanda E, Choi Y, Kahn JG. HPV-based cervical cancer screening in low-resource settings: Maximizing the efficiency of community-based strategies in rural Kenya. Int J Gynaecol Obstet. 2020 Mar; 148(3):386-391. View on Pubmed
  5. Levy R, Mathai M, Chatterjee P, Ongeri L, Njuguna S, Onyango D, Akena D, Rota G, Otieno A, Neylan TC, Lukwata H, Kahn JG, Cohen CR, Bukusi D, Aarons GA, Burger R, Blum K, Nahum-Shani I, McCulloch CE, Meffert SM. Implementation research for public sector mental health care scale-up (SMART-DAPPER): a sequential multiple, assignment randomized trial (SMART) of non-specialist-delivered psychotherapy and/or medication for major depressive disorder and posttraumatic stress disorder (DAPPER) integrated with outpatient care clinics at a county hospital in Kenya. BMC Psychiatry. 2019 Dec 28; 19(1):424. View on Pubmed
  6. Cerecero-García D, Pineda-Antunez C, Alexander L, Cameron D, Martinez-Silva G, Obure CD, Marseille E, Vu L, Kahn JG, Vassall A, Gomez G, Bollinger L, Levin C, Bautista-Arredondo S. A meta-analysis approach for estimating average unit costs for ART using pooled facility-level primary data from African countries. Afr J AIDS Res. 2019 Dec; 18(4):297-305. View on Pubmed
  7. DeCormier Plosky W, Bollinger LA, Alexander L, Cameron DB, Carroll LN, Cunnama L, Gomez GB, Levin C, Marseille E, Mustafa Diab M, Siapka M, Sinanovic E, Vassall A, Kahn JG. Developing the Global Health Cost Consortium Unit Cost Study Repository for HIV and TB: methodology and lessons learned. Afr J AIDS Res. 2019 Dec; 18(4):263-276. View on Pubmed
  8. Pineda-Antunez C, Martinez-Silva G, Cerecero-Garcia D, Alexander L, Cameron DB, Chiwevu C, Dandona L, Obure CD, Forsythe S, Nguyen VT, Settumba S, Tchuenche M, Van Minh H, Kahn JG, Gomez G, Sweeney S, Vassall A, Bollinger L, Levin C, Bautista-Arredondo S. Meta-analysis of average costs of HIV testing and counselling and voluntary medical male circumcision across thirteen countries. Afr J AIDS Res. 2019 Dec; 18(4):341-349. View on Pubmed
  9. Cameron DB, Mustafa Diab M, Carroll LN, Bollinger LA, DeCormier Plosky W, Levin C, Herzel B, Marseille E, Alexander L, Bautista-Arredondo S, Pineda-Antunez C, Cerecero-García D, Gomez GB, Dow WH, Kahn JG. The state of costing research for HIV interventions in sub-Saharan Africa. Afr J AIDS Res. 2019 Dec; 18(4):277-288. View on Pubmed
  10. Shete PB, Kahn JG. Economic analyses to inform public health decision-making for tuberculosis: the role of understanding implementation. BMC Med. 2019 11 29; 17(1):224. View on Pubmed
  11. Williams BA, Li A, Ahalt C, Coxson P, Kahn JG, Bibbins-Domingo K. The Cardiovascular Health Burdens of Solitary Confinement. J Gen Intern Med. 2019 Oct; 34(10):1977-1980. View on Pubmed
  12. Possin KL, Merrilees JJ, Dulaney S, Bonasera SJ, Chiong W, Lee K, Hooper SM, Allen IE, Braley T, Bernstein A, Rosa TD, Harrison K, Begert-Hellings H, Kornak J, Kahn JG, Naasan G, Lanata S, Clark AM, Chodos A, Gearhart R, Ritchie C, Miller BL. Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial. JAMA Intern Med. 2019 Sep 30. View on Pubmed
  13. Miller AP, Malekinejad M, Horváth H, Blodgett JC, Kahn JG, Marks SM. Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review. PLoS One. 2019; 14(9):e0223077. View on Pubmed
  14. Rosa TD, Possin KL, Bernstein A, Merrilees J, Dulaney S, Matuoka J, Lee KP, Chiong W, Bonasera SJ, Harrison KL, Kahn JG. Variations in Costs of a Collaborative Care Model for Dementia. J Am Geriatr Soc. 2019 Dec; 67(12):2628-2633. View on Pubmed
  15. Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. Outlook for tuberculosis elimination in California: An individual-based stochastic model. PLoS One. 2019; 14(4):e0214532. View on Pubmed
  16. Marseille E, Kahn JG. Utilitarianism and the ethical foundations of cost-effectiveness analysis in resource allocation for global health. Philos Ethics Humanit Med. 2019 04 03; 14(1):5. View on Pubmed
  17. Cepeda JA, Burgos JL, Kahn JG, Padilla R, Meza Martinez PE, Segovia LA, Gaines T, Abramovitz D, Rangel G, Magis-Rodriguez C, Vickerman P, Strathdee SA, Martin NK. Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysis. BMJ Open. 2019 01 29; 9(1):e026298. View on Pubmed
  18. Mustafa Diab M, Shearer DW, Kahn JG, Wu HH, Lau B, Morshed S, Chokotho L. The Cost of Intramedullary Nailing Versus Skeletal Traction for Treatment of Femoral Shaft Fractures in Malawi: A Prospective Economic Analysis. World J Surg. 2019 01; 43(1):87-95. View on Pubmed
  19. Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG. Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States. Open Forum Infect Dis. 2019 Jan; 6(1):ofy353. View on Pubmed
  20. Chomsky-Higgins K, Kahn JG. Interventions and Innovation to Prevent Surgical Site Infection in Colorectal Surgery: A Cost-Effectiveness Analysis. J Surg Res. 2019 03; 235:373-382. View on Pubmed
  21. Matuoka JY, Kahn JG, Secoli SR. Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review. Eur J Health Econ. 2019 Jun; 20(4):487-499. View on Pubmed
  22. Parriott A, Malekinejad M, Miller AP, Horvath H, Marks SM, Kahn JG. Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review. PLoS One. 2018; 13(7):e0200485. View on Pubmed
  23. Chamie G, Schaffer EM, Ndyabakira A, Emperador DM, Kwarisiima D, Camlin CS, Havlir DV, Kahn JG, Kamya MR, Thirumurthy H. Comparative effectiveness of novel nonmonetary incentives to promote HIV testing. AIDS. 2018 07 17; 32(11):1443-1451. View on Pubmed
  24. Herzel BJ, Samuel SP, Bulfone TC, Raj CS, Lewin M, Kahn JG. Snakebite: An Exploratory Cost-Effectiveness Analysis of Adjunct Treatment Strategies. Am J Trop Med Hyg. 2018 08; 99(2):404-412. View on Pubmed
  25. Shen J, Olwanda E, Kahn JG, Huchko MJ. Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya. BMC Health Serv Res. 2018 05 25; 18(1):378. View on Pubmed
  26. Burgos JL, Cepeda JA, Kahn JG, Mittal ML, Meza E, Lazos RRP, Vargas PC, Vickerman P, Strathdee SA, Martin NK. Cost of provision of opioid substitution therapy provision in Tijuana, Mexico. Harm Reduct J. 2018 05 23; 15(1):28. View on Pubmed
  27. Mirzazadeh A, Biggs MA, Viitanen A, Horvath H, Wang LY, Dunville R, Barrios LC, Kahn JG, Marseille E. Do School-Based Programs Prevent HIV and Other Sexually Transmitted Infections in Adolescents? A Systematic Review and Meta-analysis. Prev Sci. 2018 05; 19(4):490-506. View on Pubmed
  28. Marseille E, Mirzazadeh A, Biggs MA, P Miller A, Horvath H, Lightfoot M, Malekinejad M, Kahn JG. Effectiveness of School-Based Teen Pregnancy Prevention Programs in the USA: a Systematic Review and Meta-Analysis. Prev Sci. 2018 05; 19(4):468-489. View on Pubmed
  29. Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis. BMC Public Health. 2018 04 12; 18(1):485. View on Pubmed
  30. Olwanda E, Shen J, Kahn JG, Bryant-Comstock K, Huchko MJ. Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study. Glob Health Action. 2018; 11(1):1451455. View on Pubmed
  31. Huchko MJ, Kahn JG, Smith JS, Hiatt RA, Cohen CR, Bukusi E. Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya. BMC Cancer. 2017 Dec 06; 17(1):826. View on Pubmed
  32. Semitala FC, Camlin CS, Wallenta J, Kampiire L, Katuramu R, Amanyire G, Namusobya J, Chang W, Kahn JG, Charlebois ED, Havlir DV, Kamya MR, Geng EH. Understanding uptake of an intervention to accelerate antiretroviral therapy initiation in Uganda via qualitative inquiry. J Int AIDS Soc. 2017 12; 20(4). View on Pubmed
  33. Chomsky-Higgins K, Seib C, Rochefort H, Gosnell J, Shen WT, Kahn JG, Duh QY, Suh I. Less is more: cost-effectiveness analysis of surveillance strategies for small, nonfunctional, radiographically benign adrenal incidentalomas. Surgery. 2018 01; 163(1):197-204. View on Pubmed
  34. Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review. PLoS One. 2017; 12(8):e0180707. View on Pubmed
  35. Malekinejad M, Parriott A, Blodgett JC, Horvath H, Shrestha RK, Hutchinson AB, Volberding P, Kahn JG. Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis. PLoS One. 2017; 12(8):e0180718. View on Pubmed
  36. Vreman RA, Goodell AJ, Rodriguez LA, Porco TC, Lustig RH, Kahn JG. Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model. BMJ Open. 2017 Aug 03; 7(8):e013543. View on Pubmed
  37. Kortz TB, Herzel B, Marseille E, Kahn JG. Bubble continuous positive airway pressure in the treatment of severe paediatric pneumonia in Malawi: a cost-effectiveness analysis. BMJ Open. 2017 Jul 10; 7(7):e015344. View on Pubmed
  38. Schillinger D, Kahn JG. Mobilizing for a war on the home front against sugar-related morbidity and mortality. Isr J Health Policy Res. 2017; 6:32. View on Pubmed
  39. Salazar J, Saxena V, Kahn JG, Roberts JP, Mehta N, Volk M, Lai JC. Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008. View on Pubmed
  40. Chang W, Chamie G, Mwai D, Clark TD, Thirumurthy H, Charlebois ED, Petersen M, Kabami J, Ssemmondo E, Kadede K, Kwarisiima D, Sang N, Bukusi EA, Cohen CR, Kamya M, Havlir DV, Kahn JG. Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa. J Acquir Immune Defic Syndr. 2016 Nov 01; 73(3):e39-e45. View on Pubmed
  41. Zygourakis CC, Imber BS, Chen R, Han SJ, Blevins L, Molinaro A, Kahn JG, Aghi MK. Cost-Effectiveness Analysis of Surgical versus Medical Treatment of Prolactinomas. J Neurol Surg B Skull Base. 2017 Apr; 78(2):125-131. View on Pubmed
  42. Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, Charlebois E, Camlin C, Kahn J, Chang W, Glidden D, Kamya M, Havlir D, Geng E. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. 2016 11; 3(11):e539-e548. View on Pubmed
  43. Goodell AJ, Kahn JG, Ndeki SS, Kaale E, Kaaya EE, Macfarlane SB. Modeling solutions to Tanzania's physician workforce challenge. Glob Health Action. 2016; 9:31597. View on Pubmed
  44. Marseille E, Kahn JG. A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact. PLoS Med. 2016 05; 13(5):e1002031. View on Pubmed
  45. Kahn J. See One, Do One, Teach One, But Practice First. J Palliat Med. 2016 Jun; 19(6):675-6. View on Pubmed
  46. Burgos JL, Patterson TL, Graff-Zivin JS, Kahn JG, Rangel MG, Lozada MR, Staines H, Strathdee SA. Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities. PLoS One. 2016; 11(2):e0147719. View on Pubmed
  47. Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan; 176(1):65-73. View on Pubmed
  48. Jain V, Chang W, Byonanebye DM, Owaraganise A, Twinomuhwezi E, Amanyire G, Black D, Marseille E, Kamya MR, Havlir DV, Kahn JG. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda. PLoS One. 2015; 10(12):e0143433. View on Pubmed
  49. Kwek SS, Kahn J, Greaney SK, Lewis J, Cha E, Zhang L, Weber RW, Leonard L, Markovic SN, Fong L, Spitler LE. GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses. Oncoimmunology. 2016 Apr; 5(4):e1101204. View on Pubmed
  50. Curl PK, Kahn JG, Ordovas KG, Elicker BM, Naeger DM. Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening. AJR Am J Roentgenol. 2015 Aug; 205(2):344-7. View on Pubmed
  51. Patel MI, Bhattacharya J, Asch SM, Kahn J. Acceptance of Advance Directives and Palliative Care Referral for Veterans With Advanced Cancer: A Retrospective Analysis. Am J Hosp Palliat Care. 2016 Sep; 33(8):742-7. View on Pubmed
  52. Kahn JG, Hofmann P. Research ethics and health care reform. Science. 2015 Jun 19; 348(6241):1325-6. View on Pubmed
  53. Verguet S, Kahn JG, Marseille E, Jiwani A, Kern E, Walson JL. Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya? Glob Health Action. 2015; 8:27695. View on Pubmed
  54. Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG. Correction: Cost-Effectiveness Of Treatment Strategies for BRAF-Mutated Metastatic Melanoma. PLoS One. 2015; 10(4):e0126988. View on Pubmed
  55. Chen IT, Aung T, Thant HN, Sudhinaraset M, Kahn JG. Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar. Malar J. 2015 Feb 05; 14:55. View on Pubmed
  56. Juillard C, Smith R, Anaya N, Garcia A, Kahn JG, Dicker RA. Saving lives and saving money: hospital-based violence intervention is cost-effective. J Trauma Acute Care Surg. 2015 Feb; 78(2):252-7; discussion 257-8. View on Pubmed
  57. Downing J, El Ayadi A, Miller S, Butrick E, Mkumba G, Magwali T, Kaseba-Sata C, Kahn JG. Cost-effectiveness of the non-pneumatic anti-shock garment (NASG): evidence from a cluster randomized controlled trial in Zambia and Zimbabwe. BMC Health Serv Res. 2015 Jan 28; 15:37. View on Pubmed
  58. Mirzazadeh A, Malekinejad M, Kahn JG. Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research. J Clin Epidemiol. 2015 Mar; 68(3):317-23. View on Pubmed
  59. Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015 Feb 01; 93(2):118-24. View on Pubmed
  60. Jiwani A, Himmelstein D, Woolhandler S, Kahn JG. Billing and insurance-related administrative costs in United States' health care: synthesis of micro-costing evidence. BMC Health Serv Res. 2014 Nov 13; 14:556. View on Pubmed
  61. Zygourakis CC, Kahn JG. Cost-effectiveness research in neurosurgery. Neurosurg Clin N Am. 2015 Apr; 26(2):189-96, viii. View on Pubmed
  62. Zygourakis CC, Oh T, Sun MZ, Barani I, Kahn JG, Parsa AT. Surgery is cost-effective treatment for young patients with vestibular schwannomas: decision tree modeling of surgery, radiation, and observation. Neurosurg Focus. 2014 Nov; 37(5):E8. View on Pubmed
  63. Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG. Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma. PLoS One. 2014; 9(9):e107255. View on Pubmed
  64. Marseille E, Kahn JG. Avahan and the cost-effectiveness of "prevention as prevention". Lancet Glob Health. 2014 Sep; 2(9):e493-e494. View on Pubmed
  65. Weile LK, Kahn JG, Marseille E, Jensen DM, Damm P, Lohse N. Global cost-effectiveness of GDM screening and management: current knowledge and future needs. Best Pract Res Clin Obstet Gynaecol. 2015 Feb; 29(2):206-24. View on Pubmed
  66. Lima VD, Thirumurthy H, Kahn JG, Saavedra J, Cárceres CF, Whiteside A. Modeling scenarios for the end of AIDS. Clin Infect Dis. 2014 Jul; 59 Suppl 1:S16-20. View on Pubmed
  67. Marseille E, Jiwani A, Raut A, Verguet S, Walson J, Kahn JG. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries. BMJ Open. 2014 Jun 26; 4(6):e003987. View on Pubmed
  68. Jiwani A, Matheson A, Kahn JG, Raut A, Verguet S, Marseille E, Walson J. Integrated disease prevention campaigns: assessing country opportunity for implementation via an index approach. BMJ Open. 2014 Mar 19; 4(3):e004308. View on Pubmed
  69. Lai JC, Kahn JG, Roberts JP. Author response: reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2014 Apr; 14(4):981. View on Pubmed
  70. Kahn JG, Jiwani A, Gomez GB, Hawkes SJ, Chesson HW, Broutet N, Kamb ML, Newman LM. The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model. PLoS One. 2014; 9(1):e87510. View on Pubmed
  71. Marseille E, Kahn JG, Beatty S, Jared M, Perchal P. Adult male circumcision in Nyanza, Kenya at scale: the cost and efficiency of alternative service delivery modes. BMC Health Serv Res. 2014 Jan 23; 14:31. View on Pubmed
  72. Kahn JG, Marseille EA. Capsule commentary on Long and Stavert, portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. J Gen Intern Med. 2013 Oct; 28(10):1350. View on Pubmed
  73. Lai JC, Kahn JG, Tavakol M, Peters MG, Roberts JP. Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2013 Oct; 13(10):2611-8. View on Pubmed
  74. Yanik EL, Napravnik S, Ryscavage P, Eron JJ, Koletar SL, Moore RD, Zinski A, Cole SR, Hunt P, Crane HM, Kahn J, Mathews WC, Mayer KH, Taiwo BO. Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010. J Acquir Immune Defic Syndr. 2013 Jun 01; 63(2):216-20. View on Pubmed
  75. Kahn JG, Marseille EA. Viral load monitoring for antiretroviral therapy in resource-poor settings: an evolving role. AIDS. 2013 Jun 01; 27(9):1509-11. View on Pubmed
  76. Kern E, Verguet S, Yuhas K, Odhiambo FH, Kahn JG, Walson J. Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study. Trop Med Int Health. 2013 Aug; 18(8):916-24. View on Pubmed
  77. Sutherland T, Downing J, Miller S, Bishai DM, Butrick E, Fathalla MM, Mourad-Youssif M, Ojengbede O, Nsima D, Kahn JG. Use of the non-pneumatic anti-shock garment (NASG) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in Egypt and Nigeria. PLoS One. 2013; 8(4):e62282. View on Pubmed
  78. Audureau E, Kahn JG, Besson MH, Saba J, Ladner J. Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance. BMC Public Health. 2013 Apr 01; 13:286. View on Pubmed
  79. Marseille E, Lohse N, Jiwani A, Hod M, Seshiah V, Yajnik CS, Arora GP, Balaji V, Henriksen O, Lieberman N, Chen R, Damm P, Metzger BE, Kahn JG. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med. 2013 May; 26(8):802-10. View on Pubmed
  80. Velayos FS, Kahn JG, Sandborn WJ, Feagan BG. A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab. Clin Gastroenterol Hepatol. 2013 Jun; 11(6):654-66. View on Pubmed
  81. Marseille E, Giganti MJ, Mwango A, Chisembele-Taylor A, Mulenga L, Over M, Kahn JG, Stringer JS. Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia. PLoS One. 2012; 7(12):e51993. View on Pubmed
  82. Abeyasinghe RR, Galappaththy GN, Smith Gueye C, Kahn JG, Feachem RG. Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One. 2012; 7(8):e43162. View on Pubmed
  83. Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, Sabin ML, Makhlouf-Obermeyer C, De Filippo Mack C, Williams P, Jones L, Smyth C, Kutch KA, Ying-Ru L, Vitoria M, Souteyrand Y, Crowley S, Korenromp EL, Williams BG. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One. 2012; 7(2):e30216. View on Pubmed
  84. Kahn JG, Muraguri N, Harris B, Lugada E, Clasen T, Grabowsky M, Mermin J, Shariff S. Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness. PLoS One. 2012; 7(2):e31316. View on Pubmed
  85. Kahn JG, Harris B, Mermin JH, Clasen T, Lugada E, Grabowksy M, Vestergaard Frandsen M, Garg N. Cost of community integrated prevention campaign for malaria, HIV, and diarrhea in rural Kenya. BMC Health Serv Res. 2011 Dec 21; 11:346. View on Pubmed
  86. Marseille EA, Kevany S, Ahmed I, Feleke G, Graham B, Heller T, Kahn JG, Reyes M. Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study. Cost Eff Resour Alloc. 2011 Dec 20; 9:18. View on Pubmed
  87. Kahn JG, Marseille E, Moore D, Bunnell R, Were W, Degerman R, Tappero JW, Ekwaru P, Kaharuza F, Mermin J. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011 Nov 09; 343:d6884. View on Pubmed
  88. Lohse N, Marseille E, Kahn JG. Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus. Int J Gynaecol Obstet. 2011 Nov; 115 Suppl 1:S20-5. View on Pubmed
  89. Bozic KJ, Chiu V, Slover JD, Immerman I, Kahn JG. Patient preferences and willingness to pay for arthroplasty surgery in patients with osteoarthritis of the hip. J Arthroplasty. 2012 Apr; 27(4):503-506.e2. View on Pubmed
  90. Tatarsky A, Aboobakar S, Cohen JM, Gopee N, Bheecarry A, Moonasar D, Phillips AA, Kahn JG, Moonen B, Smith DL, Sabot O. Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS One. 2011; 6(9):e23832. View on Pubmed
  91. Kahn JG, Marseille EA, Bennett R, Williams BG, Granich R. Cost-effectiveness of antiretroviral therapy for prevention. Curr HIV Res. 2011 Sep; 9(6):405-15. View on Pubmed
  92. Jones L, Akugizibwe P, Clayton M, Amon JJ, Sabin ML, Bennett R, Stegling C, Baggaley R, Kahn JG, Holmes CB, Garg N, Obermeyer CM, Mack CD, Williams P, Smyth C, Vitoria M, Crowley S, Williams B, McClure C, Granich R, Hirnschall G. Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting. Curr HIV Res. 2011 Sep; 9(6):416-28. View on Pubmed
  93. Granich R, Lo YR, Suthar AB, Vitoria M, Baggaley R, Obermeyer CM, McClure C, Souteyrand Y, Perriens J, Kahn JG, Bennett R, Smyth C, Williams B, Montaner J, Hirnschall G. Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis. Curr HIV Res. 2011 Sep; 9(6):355-66. View on Pubmed
  94. Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med. 2012 Jun; 25(6):600-10. View on Pubmed
  95. De Ver Dye T, Apondi R, Lugada E, Kahn JG, Sandiford-Day MA, Dasbanerjee T. A qualitative assessment of beliefs, attitudes, and behaviors related to diarrhea and water filtration in rural Kenya. Am J Public Health. 2011 Aug; 101(8):1515-20. View on Pubmed
  96. Bozic KJ, Chiu VW, Slover JD, Immerman I, Kahn JG. Health state utility in patients with osteoarthritis of the hip and total hip arthroplasty. J Arthroplasty. 2011 Sep; 26(6 Suppl):129-132.e1-2. View on Pubmed
  97. Dye TD, Apondi R, Lugada ES, Kahn JG, Smith J, Othoro C. "Before we used to get sick all the time": perceptions of malaria and use of long-lasting insecticide-treated bed nets (LLINs) in a rural Kenyan community. Malar J. 2010 Nov 30; 9:345. View on Pubmed
  98. Sabot O, Cohen JM, Hsiang MS, Kahn JG, Basu S, Tang L, Zheng B, Gao Q, Zou L, Tatarsky A, Aboobakar S, Usas J, Barrett S, Cohen JL, Jamison DT, Feachem RG. Costs and financial feasibility of malaria elimination. Lancet. 2010 Nov 06; 376(9752):1604-15. View on Pubmed
  99. Lugada E, Millar D, Haskew J, Grabowsky M, Garg N, Vestergaard M, Kahn JG, Khan JG, Kahn J, Muraguri N, Mermin J. Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One. 2010 Aug 26; 5(8):e12435. View on Pubmed
  100. Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, Bennett R, Lo YR, Souteyrand Y, Williams B. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS. 2010 Jul; 5(4):298-304. View on Pubmed
  101. Kahn JG, Yang JS, Kahn JS. 'Mobile' health needs and opportunities in developing countries. Health Aff (Millwood). 2010 Feb; 29(2):252-8. View on Pubmed
  102. Doyle SM, Kahn JG, Hosang N, Carroll PR. The impact of male circumcision on HIV transmission. J Urol. 2010 Jan; 183(1):21-6. View on Pubmed
  103. Breban R, Napravnik S, Kahn J, Blower S. Quantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling. BMC Public Health. 2009 Nov 18; 9 Suppl 1:S11. View on Pubmed
  104. Burgos JL, Kahn JG, Strathdee SA, Valencia-Mendoza A, Bautista-Arredondo S, Laniado-Laborin R, Castañeda R, Deiss R, Garfein RS. Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico. Int J Tuberc Lung Dis. 2009 Aug; 13(8):962-8. View on Pubmed
  105. Sakowski JA, Kahn JG, Kronick RG, Newman JM, Luft HS. Peering into the black box: billing and insurance activities in a medical group. Health Aff (Millwood). 2009 Jul-Aug; 28(4):w544-54. View on Pubmed
  106. Marseille E, Kahn JG, Pitter C, Bunnell R, Epalatai W, Jawe E, Were W, Mermin J. The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Appl Health Econ Health Policy. 2009; 7(4):229-43. View on Pubmed
  107. Auvert B, Marseille E, Korenromp EL, Lloyd-Smith J, Sitta R, Taljaard D, Pretorius C, Williams B, Kahn JG. Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One. 2008 Aug 06; 3(8):e2679. View on Pubmed
  108. Dandona L, Kumar SP, Ramesh Y, Rao MC, Kumar AA, Marseille E, Kahn JG, Dandona R. Changing cost of HIV interventions in the context of scaling-up in India. AIDS. 2008 Jul; 22 Suppl 1:S43-9. View on Pubmed
  109. Kürzinger ML, Pagnier J, Kahn JG, Hampshire R, Wakabi T, Dye TD. Education status among orphans and non-orphans in communities affected by AIDS in Tanzania and Burkina Faso. AIDS Care. 2008 Jul; 20(6):726-32. View on Pubmed
  110. Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, Hearst N, Wamai RG, Kahn JG, Walsh J. Public health. Reassessing HIV prevention. Science. 2008 May 09; 320(5877):749-50. View on Pubmed
  111. Kahn J, Des Jarlais CD, Dobkin L, Barrs SF, Greenblatt RM. Mentoring the next generation of HIV prevention researchers: a model mentoring program at the University of California San Francisco and Gladstone Institute of Immunology and Virology Center for AIDS research. J Acquir Immune Defic Syndr. 2008 Mar 01; 47 Suppl 1:S5-9. View on Pubmed
  112. Dandona L, Kumar SG, Ramesh YK, Rao MC, Marseille E, Kahn JG, Dandona R. Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India. BMC Health Serv Res. 2008 Jan 31; 8:26. View on Pubmed
  113. Marseille E, Dandona L, Marshall N, Gaist P, Bautista-Arredondo S, Rollins B, Bertozzi SM, Coovadia J, Saba J, Lioznov D, Du Plessis JA, Krupitsky E, Stanley N, Over M, Peryshkina A, Kumar SG, Muyingo S, Pitter C, Lundberg M, Kahn JG. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res. 2007 Jul 12; 7:108. View on Pubmed
  114. Pitter C, Kahn JG, Marseille E, Lule JR, McFarland DA, Ekwaru JP, Bunnell R, Coutinho A, Mermin J. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. J Acquir Immune Defic Syndr. 2007 Mar 01; 44(3):336-43. View on Pubmed
  115. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006 Dec; 3(12):e517. View on Pubmed
  116. Gardner A, Kahn JG. Increasing access to care for the uninsured: considering the options in California counties. J Health Care Poor Underserved. 2006 Nov; 17(4):830-50. View on Pubmed
  117. Wilson DP, Kahn J, Blower SM. Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban-rural divide. Proc Natl Acad Sci U S A. 2006 Sep 19; 103(38):14228-33. View on Pubmed
  118. Shrestha RK, Marseille E, Kahn JG, Lule JR, Pitter C, Blandford JM, Bunnell R, Coutinho A, Kizito F, Quick R, Mermin J. Cost-effectiveness of home-based chlorination and safe water storage in reducing diarrhea among HIV-affected households in rural Uganda. Am J Trop Med Hyg. 2006 May; 74(5):884-90. View on Pubmed
  119. Marseille E, Saba J, Muyingo S, Kahn JG. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda. AIDS. 2006 Apr 04; 20(6):907-14. View on Pubmed
  120. Bozic KJ, Morshed S, Silverstein MD, Rubash HE, Kahn JG. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am. 2006 Apr; 88(4):706-14. View on Pubmed
  121. Ikard K, Janney J, Hsu LC, Isenberg DJ, Scalco MB, Schwarcz S, Beer L, Wendell DA, Franks PE, Kahn JG. Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Educ Prev. 2005 Dec; 17(6 Suppl B):26-38. View on Pubmed
  122. McConnel CE, Stanley N, du Plessis JA, Pitter CS, Abdulla F, Coovadia HM, Marseille E, Kahn JG. The cost of a rapid-test VCT clinic in South Africa. S Afr Med J. 2005 Dec; 95(12):968-71. View on Pubmed
  123. Dandona L, Sisodia P, Prasad TL, Marseille E, Chalapathi Rao M, Kumar AA, Kumar SG, Ramesh YK, Over M, Someshwar M, Kahn JG. Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India. BMC Health Serv Res. 2005 Nov 05; 5:69. View on Pubmed
  124. Kahn JG, Kronick R, Kreger M, Gans DN. The cost of health insurance administration in California: estimates for insurers, physicians, and hospitals. Health Aff (Millwood). 2005 Nov-Dec; 24(6):1629-39. View on Pubmed
  125. Dandona L, Sisodia P, Kumar SG, Ramesh YK, Kumar AA, Rao MC, Marseille E, Someshwar M, Marshall N, Kahn JG. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency. BMC Public Health. 2005 Sep 24; 5:98. View on Pubmed
  126. Buchmueller TC, Grumbach K, Kronick R, Kahn JG. The effect of health insurance on medical care utilization and implications for insurance expansion: a review of the literature. Med Care Res Rev. 2005 Feb; 62(1):3-30. View on Pubmed
  127. Blower S, Bodine E, Kahn J, McFarland W. The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS. 2005 Jan 03; 19(1):1-14. View on Pubmed
  128. Dandona L, Sisodia P, Ramesh YK, Kumar SG, Kumar AA, Rao MC, Someshwar M, Hansl B, Marshall N, Marseille E, Kahn JG. Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India. Natl Med J India. 2005 Jan-Feb; 18(1):26-31. View on Pubmed
  129. Marseille E, Dandona L, Saba J, McConnel C, Rollins B, Gaist P, Lundberg M, Over M, Bertozzi S, Kahn JG. Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project. Health Serv Res. 2004 Dec; 39(6 Pt 2):1993-2012. View on Pubmed
  130. Wilson AR, Kahn JG. Preventing HIV in injection drug users: choosing the best mix of interventions for the population. J Urban Health. 2003 Sep; 80(3):465-81. View on Pubmed
  131. Jacobson MA, Liu L, Khayam-Bashi H, Deeks SG, Hecht FM, Kahn J. Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy. AIDS. 2003 Apr 11; 17(6):917-9. View on Pubmed
  132. Bitton A, Kahn JG. MSJAMA: Government share of health care expenditures. JAMA. 2003 Mar 05; 289(9):1165. View on Pubmed
  133. Kahn J. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men. Clin Infect Dis. 2002 Dec 01; 35(11):1382-7. View on Pubmed
  134. Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr. 2002 Oct 01; 31(2):237-42. View on Pubmed
  135. Marseille E, Hofmann PB, Kahn JG. HIV prevention before HAART in sub-Saharan Africa. Lancet. 2002 May 25; 359(9320):1851-6. View on Pubmed
  136. Kahn JG, Zhang X, Cross LT, Palacio H, Birkhead GS, Morin SF. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S. Public Health Rep. 2002 May-Jun; 117(3):252-62; discussion 231-2. View on Pubmed
  137. Palacio H, Kahn JG, Richards TA, Morin SF. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep. 2002 May-Jun; 117(3):233-51; discussion 231-2. View on Pubmed
  138. Morin SF, Sengupta S, Cozen M, Richards TA, Shriver MD, Palacio H, Kahn JG. Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies. Public Health Rep. 2002 May-Jun; 117(3):263-72; discussion 231-2. View on Pubmed
  139. Kahn JG, Marseille E. A saga in international HIV policy modeling: preventing mother-to-child HIV transmission. J Policy Anal Manage. 2002; 21(3):499-505. View on Pubmed
  140. Heumann KS, Marx R, Lawrence SJ, Stump DL, Carroll DP, Hirozawa AM, Katz MH, Kahn JG. Cost-effectiveness of prevention referrals for high-risk HIV-negatives in San Francisco. AIDS Care. 2001 Oct; 13(5):637-42. View on Pubmed
  141. Kahn JG, Haile B, Kates J, Chang S. Health and federal budgetary effects of increasing access to antiretroviral medications for HIV by expanding Medicaid. Am J Public Health. 2001 Sep; 91(9):1464-73. View on Pubmed
  142. Kahn JG, Kegeles SM, Hays R, Beltzer N. Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men. J Acquir Immune Defic Syndr. 2001 Aug 15; 27(5):482-91. View on Pubmed
  143. Eichner J, Kahn JG. Coordination of health coverage for Medicare enrollees: living with HIV/AIDS in California. Medicare Brief. 2001 Aug; (8):1-10. View on Pubmed
  144. Kahn JG. Expenditures for the care of patients with HIV. N Engl J Med. 2001 Jun 21; 344(25):1948-9. View on Pubmed
  145. Marseille E, Kahn JG, Billinghurst K, Saba J. Cost-effectiveness of the female condom in preventing HIV and STDs in commercial sex workers in rural South Africa. Soc Sci Med. 2001 Jan; 52(1):135-48. View on Pubmed
  146. Kahn JG, Marseille E. Fighting global AIDS: the value of cost-effectiveness analysis. AIDS. 2000 Nov 10; 14(16):2609-10. View on Pubmed
  147. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa. Ann N Y Acad Sci. 2000 Nov; 918:53-6. View on Pubmed
  148. Pinkerton SD, Holtgrave DR, Kahn JG. Is post-exposure prophylaxis affordable? AIDS. 2000 Feb 18; 14(3):325. View on Pubmed
  149. Kahn JG, Becker BJ, MacIsaa L, Amory JK, Neuhaus J, Olkin I, Creinin MD. The efficacy of medical abortion: a meta-analysis. Contraception. 2000 Jan; 61(1):29-40. View on Pubmed
  150. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999 Sep 04; 354(9181):803-9. View on Pubmed
  151. Johnston SC, Gress DR, Kahn JG. Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology. 1999 Jun 10; 52(9):1806-15. View on Pubmed
  152. Kahn JG, Pinkerton SD, Paltiel AD. Postexposure prophylaxis following HIV exposure. JAMA. 1999 Apr 14; 281(14):1269-70. View on Pubmed
  153. Kahn JG, Brindis CD, Glei DA. Pregnancies averted among U.S. teenagers by the use of contraceptives. Fam Plann Perspect. 1999 Jan-Feb; 31(1):29-34. View on Pubmed
  154. Marseille E, Kahn JG, Saba J. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS. 1998 May 28; 12(8):939-48. View on Pubmed
  155. Kahn JG, Gurvey J, Pollack LM, Binson D, Catania JA. How many HIV infections cross the bisexual bridge? An estimate from the United States. AIDS. 1997 Jul; 11(8):1031-7. View on Pubmed
  156. Marx R, Franks PE, Kahn JG, Sanstad KC, Werdegar D. HIV education and prevention in California: problems and progress. HIV Education and Prevention Evaluation Team. AIDS Public Policy J. 1997; 12(1):31-45. View on Pubmed
  157. Kahn JG, Sanstad KC. The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS Public Policy J. 1997; 12(1):21-30. View on Pubmed
  158. Grover CM, Kuppermann M, Kahn JG, Washington AE. Concurrent hysterectomy at bilateral salpingo-oophorectomy: benefits, risks, and costs. Obstet Gynecol. 1996 Dec; 88(6):907-13. View on Pubmed
  159. Kahn JG. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? Am J Public Health. 1996 Dec; 86(12):1709-12. View on Pubmed
  160. McFarland W, Kahn JG, Katzenstein DA, Mvere D, Shamu R. Deferral of blood donors with risk factors for HIV infection saves lives and money in Zimbabwe. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 01; 9(2):183-92. View on Pubmed
  161. Kahn JG, Mokdad AH, Deming MS, Roungou JB, Boby AM, Excler JL, Waldman RJ. Avoiding missed opportunities for immunization in the Central African Republic: potential impact on vaccination coverage. Bull World Health Organ. 1995; 73(1):47-55. View on Pubmed
  162. Kahn JG, Luft H, Smith MD. HIV risk adjustment: issues and proposed approaches. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 8 Suppl 1:S53-66. View on Pubmed
  163. Lurie P, Avins AL, Phillips KA, Kahn JG, Lowe RA, Ciccarone D. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA. 1994 Dec 21; 272(23):1832-8. View on Pubmed
  164. Phillips KA, Lowe RA, Kahn JG, Lurie P, Avins AL, Ciccarone D. The cost-effectiveness of HIV testing of physicians and dentists in the United States. JAMA. 1994 Mar 16; 271(11):851-8. View on Pubmed
  165. Walker CK, Kahn JG, Washington AE, Peterson HB, Sweet RL. Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. J Infect Dis. 1993 Oct; 168(4):969-78. View on Pubmed
  166. Lurie P, Lowe RA, Avins AL, Phillips KA, Kahn JG, Franks PE, Ciccarone DH. Undiagnosed HIV infection in acute care hospitals. N Engl J Med. 1992 Dec 17; 327(25):1815-6. View on Pubmed
  167. Kahn JG, Lurie P, Grumbach K. Consumer choices and the American health care system. JAMA. 1992 Sep 09; 268(10):1265-6. View on Pubmed
  168. Lurie P, Kahn JG, Wolfe SM. Regulation of benzodiazepine prescription. JAMA. 1992 Jul 22-29; 268(4):472-3; author reply 473-4. View on Pubmed
  169. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA. 1991 Nov 13; 266(18):2594-604. View on Pubmed
  170. Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenbach DA, Faro S. Pelvic inflammatory disease. Key treatment issues and options. JAMA. 1991 Nov 13; 266(18):2605-11. View on Pubmed
  171. Marx R, Aral SO, Rolfs RT, Sterk CE, Kahn JG. Crack, sex, and STD. Sex Transm Dis. 1991 Apr-Jun; 18(2):92-101. View on Pubmed